ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,225, issued on Nov. 18, was assigned to ALMA MATER STUDIORUM-UNIVERSITA' DI BOLOGNA (Bologna, Italy).

"Compound for the treatment of the hemolytic-uremic syndrome" was invented by Maurizio Brigotti (Bologna, Italy), Domenica Carnicelli (Bologna, Italy), Elisa Porcellini (Forli, Italy) and Elisabetta Galassi (Bologna, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "A NAB815 compound having the following formula (I), wherein: L is OA, R1 is -Dab, R2 is -Thr, R3 is -DThr, R4 is -Dab, R5 is -Dab, R6 is -DPhe, R7 is -Leu, R8 is -Abu, R9 is -Dab, R10 is -Thr, or a pharmaceutically acceptable salt thereof is provided for a use in the treatment and/or ...